Estro Shift Solution
Estro Shift Solution, licence 80149124: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- BalanceElle, BalanceHer, Estro Aligned, Estro Balance, Estro Ease, Estro Empower, Estro Equilibrium, EstroBalance+, EstroBalance360, EstroClear Balance, EstroEquilibria, EstroGenie, EstroResQ, EstroSync, Estrocare, Estrogenius, Estrolibrium, HormoNize, House of Hormones, Questrogen
- Licence holder
- New Roots Herbal Inc.
- NPN or DIN-HM
- 80149124
- Status
- Active licence
- Licence date
- 29 May 2026
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Schisandra chinensis Source : Schisandra chinensis - fruit Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1500 mg Potency : 9.0 % Schisandrins | 150.0 mg | Not calculated |
| 3,3'-Diindolylméthane Source : Brassica oleracea var. italica - plante entière | 100.0 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Hypromellose, Poudre d'enveloppes d'Oryza sativa (Riz), Stéarate de magnésium, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Femmes | minimum: 18.0 Année(s) | 1.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps reduce the severity and duration of symptoms associated with recurrent breast pain (cyclical mastalgia). Helps to support/promote healthy estrogen metabolism/balance. Source of (an) antioxidant(s)/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of (an) antioxidant(s)/Provides (an) antioxidant(s).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80149124
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.